Novomartin Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.43 M
as on 16-11-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.89 M
as on 16-11-2024
- Revenue 7.15%
(FY 2023)
- Profit 4.55%
(FY 2023)
- Ebitda 23.48%
(FY 2023)
- Net Worth 6.30%
(FY 2023)
- Total Assets 13.33%
(FY 2023)
About Novomartin Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.43 M.
The company currently has active open charges totaling ₹2.89 M.
Sunita Gupta and Hirshikesh Kumar serve as directors at the Company.
- CIN/LLPIN
U51397BR2008PTC013582
- Company No.
013582
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Apr 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Patna, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Novomartin Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hirshikesh Kumar  | Managing Director | 21-Apr-2008 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sunita Gupta | Director | 21-Apr-2008 | Current |
Financial Performance of Novomartin Biotech.
Novomartin Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 7.15% increase. The company also saw a slight improvement in profitability, with a 4.55% increase in profit. The company's net worth moved up by a moderate rise of 6.3%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novomartin Biotech?
In 2023, Novomartin Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 18 Jun 2020 | ₹0.29 M | Open |
Bank Of India Creation Date: 27 Jul 2009 | ₹2.60 M | Open |
How Many Employees Work at Novomartin Biotech?
Novomartin Biotech has a workforce of 4 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novomartin Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novomartin Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
